Posted inGenetics
AbbVie Invests $195 Million to Expand North Chicago Manufacturing Facility
AbbVie is investing $195 million to strengthen its domestic active pharmaceutical ingredient (API) production within the U.S., with the expansion…
Posted inGenetics
Oxygenated Implant Sustains Insulin Cells in Rats, No Immunosuppression
Just as insulin therapy revolutionized life for people with type I diabetes (TID) a century ago, a new implant may…
Posted inGenetics
Bayer, Kumquat Target KRAS Variant in Up-to-$1.3B+ Cancer Collaboration
Bayer will partner with Kumquat Biosciences to develop Kumquat’s KRAS G12D inhibitor through a collaboration that could generate up to…
Posted inGenetics
Breaking the Link Between Alcohol Use and Pancreatic Cancer
Despite increasing evidence linking alcohol consumption to cancer, little is known about the biological mechanisms behind the association. Now, researchers at…
Posted inGenetics
Potential Triple Negative Breast Cancer Target in EPIC Long Noncoding RNA
Scientists at the University of Pittsburgh, together with colleagues at the University of Pittsburgh School of Medicine and University of…
Posted inGenetics
AI-Designed DNA Repair Templates Improve Gene Editing Precision
Targeted DNA editing by CRISPR technology has great potential for applications in biotechnology and gene therapy. However, precise gene editing…
Posted inGenetics
Generative AI Can Be a Tool for Bioprocessing Quality Assurance
Bioprocessing experts have a terrific opportunity to use generative AIs for applications like quality assurance, but it’s important to know…
Posted inGenetics
ML-Enhanced Modeling Improves mAb Design Space Predictions
For monoclonal antibodies (mAbs), traditional design space identification methods typically rely on expensive wet-lab experiments or in silico models that,…
Posted inGenetics
Generative AI Produces Small Enzymes for Bioprocessing
More than 20 years ago, scientists at Pfizer touted the benefits of using enzymes in various steps in bioprocessing. In…
Posted inGenetics
Surging Demand Reshaping Vector Manufacturing
Demand for adeno-associated viral (AAV) vectors is increasing as more and more cell and gene therapy firms use them to…